Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Mycoplasma Testing Market size, value Forecast Research Reports

Market Data Forecast
Posted on: 22 Sep 17
Global Mycoplasma Testing Market size, value Forecast Research Reports

The Global mycoplasma testing market was worth USD 465.1 Million in 2016 and is estimated to be growing at a CAGR of 12.7%, to reach USD 845.7 Million by 2021. Mycoplasma is a type of bacteria and they do not possess a cell wall or cell membrane. Since most of the common antibiotics are designed to target cell wall synthesis; they do not work against Mycoplasma. They are one of the smallest bacteria and cannot be observed using a normal microscope.

Browse Full Report @ http://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/

Mycoplasmas are more frequently found as contaminants in cell culture research laboratories. The contamination can either be carried inside by an individual or from the materials brought from outside the laboratory. In order to prevent further contamination, mycoplasma testing is recommended for all cell culturists. There are many mycoplasma tests available in the market. Mycoplasma infections cannot be allowed to grow in cell culture as they tend to bring changes in chromosomes and affect the cell growth.

Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/request-sample

As the investments in research and development are increasing in the field of life sciences, the increase in demand for mycoplasma testing products is predicted in the forecast period. With the increase in healthcare expenditure all over the world, pharmaceutical and biotechnology industries are heavily investing in R&D activities. Government Initiatives are funding research on drug discovery and development. All these factors are responsible for driving the growth of mycoplasma testing market. However, strict government regulations and high costs of mycoplasma testing are the major restraining factors for the market.

Inquire before buying report @ http://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/request-discount

Market Segmentation                                              

Product                        

Kits & Reagent       
PCR Assays
Nucleic Acid Detection Kits
Elimination Kits & Reagents
Stains
Standards & Controls
Other Kits & Reagents
Instruments           
Services    
Y-o-Y Growth Analysis, By Product              
Market Attractiveness Analysis, By Product            
Market Share Analysis, By  Product             

Technique                   

PCR            
ELSA           
Direct Assays          
Indirect Assays      
Microbial culture techniques           
Enzymatic Methods            
DNA Staining          
Y-o-Y Growth Analysis, By Technique          
Market Attractiveness Analysis, By Technique      
Market Share Analysis, By Technique       

Application                 

Cell Line Testing    
Virus Testing          
End-Of-Production Cell Testing      
Other Applications               
Y-o-Y Growth Analysis, By Application         
Market Attractiveness Analysis, By Application      
Market Share Analysis, By Application       

End User                      

Pharmaceutical Companies              
Contract Research Organizations   
Academic Research Institutes         
Cell Banks
Y-o-Y Growth Analysis, By End User             
Market Attractiveness Analysis, By End User           
Market Share Analysis, By End User  

On the basis of geography, the market for mycoplasma testing is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America dominates the mycoplasma testing market and Europe is not far behind. Asia-Pacific region is projected to have the fastest growth rate due to the huge opportunities available in countries like China, India and Japan. Increasing pharma and biotech companies and their investments in R&D and various government initiatives are expected to drive the market growth.

The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases              

For more information:
www.marketdataforecast.com

Editor's Details

Shivakrishna
Market Data Forecast
www.marketdataforecast.com
1-888-702-9626
shiva@marketdataforecast.com

Last updated on: 22/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.